Targeting HRR Pathway

CME Applied with Singapore Medical Council


for the 5th International BRCA Forum 13 AUGUST 2021 which will be one of the foremost International Scientific Virtual Forum on Hereditary Cancer

Young Women's Forum - 12 August 2021 | iBRCAf Forum - 13 August 2021 | APGCS - 14 &15 August 2021


Video Streaming & Interaction


  • Live Agenda Session Video Streaming
  • Live Stream Conference Sessions, Networking and Interaction
  • Allow Remote Attendees to Participate in Live Polling
  • Questions can be asked Live from Anywhere
  • Easily cycle between Sessions, Video, Comments and Q&A


  • Virtual Face to Face Meetings
  • Connect with Onsite and Offsite Participants
  • In-App live video calling & Instant Messaging
  • Meeting Alerts with custom emails and push notifications
Exhibitors and Sponsors


  • Includes a Filterable, Tiered Directory of Sponsors/Exhibitors
  • Dedicated Profile for each Company including Information, Downloads, Products And Video
  • Interact with Assigned Representatives immediately
  • Virtual Industry Sponsored Satellite Symposia
Virtual Meeting


  • All Features Available via a Dedicated Web Link
  • Offsite participants provided with a Virtual Meeting Automatically
  • Stream Live via a Laptop or Desktop
  • Login to a native device simultaneously
  • Full screen mode for streaming to large monitors


Dear All,

Greetings on behalf of the International BRCA Forum (iBRCAf) team 2021 to be held on 13 Aug 2021 on Virtual Format.

Our initiative of taking forward the BRCA Forum is to be connected with each other, discuss new research and findings, share experiences and understand gaps in our daily clinical practice to work towards a common goal which is always to ensure better care.

Over the past four years, the committee has delivered important topics by most renowned researchers and senior opinion leaders and established a core discussion for the medical fraternity in the Asia Pacific region. Growth of the meeting has only been possible with extended support from core groups, institutes and organizations on a year-on-year basis and has helped us realize our quest in BRCA mutation studies and we thank all of you for joining the journey with us.

With the travel and meeting protocols still very delicate and complex, the committee has decided to organize a virtual meeting once again for the 5th edition. The edition will review past edition discussion with milestone achievements, interesting interdisciplinary discussions, core research, and keynote highlights with theme-based tumor boards. iBRCAf2021 will be once again in conjunction with the Asia Pacific Gastroenterology Cancer Summit (APGCS) therefore you can enjoy three days of engaging discussions which will be CME accredited.

We welcome you all and if you have any thoughts please do write to us.


Shaheenah Dawood

Shaheenah Dawood

Shona Nag

Shona Nag

Joanne Ngeow

Joanne Ngeow


  • Pathogenesis of BRCA pathway
  • Clinical applications of PARP inhibitors across solid tumor types
  • Molecular tumor boards using molecular profiling of solid tumors
  • Defining importance of profiling tumors for personalized approaches to therapeutic management
  • Handling toxicities of targeted therapy including PARPi and beyond
  • Genetic counseling of patients with germline mutations
  • Deep dive into interpreting molecular profiling reports
  • A global look at BRCA mutations


  • Oncologist
  • Physician
  • Nurse
  • General Practitioner
  • Resident
  • Consultant
  • Obs-Gyne
  • Pharmacist

2021 Supported by

2021 Platinum Virtual Sponsor

2021 Gold Virtual Sponsor


2021 Networking Sponsor

2021 Media Partner

DISCLAIMER: The 5th International BRCA Forum (iBRCAf) 2021 is virtual educational event for Asia Pacific Healthcare professionals. Mention of commercial products, processes, or services throughout the event cannot be construed as an endorsement or recommendation for viewers inside or outside the Asia Pacific Region. Information contained in this event is intended for educational purposes only, you are solely responsible for ensuring compliance with the laws of your specific jurisdiction.